JPMorgan joins Goldman, hikes euro area's 2025 economic growth forecast
J.P.Morgan joined Wall-Street peer Goldman Sachs to forecast a boost to the euro area's economic growth for 2025 on the back ...
JPMorgan is increasingly worried a second-half stock market rally won’t happen
And to be fair, JPMorgan really was a reluctant bull anyway. The bank parted ways with Marko Kolanovic after his bearish ...
JPMorgan Said It Suspected Staley Involved in Epstein Crimes
JPMorgan Chase & Co. told British regulators it believed Jes Staley might have been involved in Jeffrey Epstein’s crimes, ...
Jamie Dimon Cashed Out $234 Million In JPMorgan Stock, Warren Buffett Stockpiled $334 Billion In Cash — Weeks Later, Markets Crashed. Coincidence?
Two of Wall Street's most influential figures took significant financial actions just days before a major market downturn, ...
JPMorgan Chase Is Oversold
But making JPMorgan Chase & Co an even more interesting and timely stock to look at, is the fact that in trading on Friday, ...
Should You Buy JPMorgan Chase's Stock at an All-Time High?
For dividend investors, it is notable that JPMorgan Chase's roughly 2% dividend yield is near the low end of its 10-year ...
If You Invested $1,000 In JPMorgan Chase Stock When Jamie Dimon Became The CEO, Here's How Much You'd Have Today
JPMorgan CEO Jamie Dimon has served in the role for more than 15 years. A look back at an investment in JPM stock when he ...
Dollar Has Its Worst Week Since 2022 as JPMorgan Turns Bearish
A gauge of the dollar finished its worst week in over two years as traders turn sour on US exceptionalism, giving rise to ...
JPMorgan Questions Viability of US Crypto Reserve, Cites Issues With Smaller Tokens
A senior JPMorgan Chase & Co (NASDAQ:JPM) strategist voiced doubts about the feasibility of establishing a U.S. strategic ...
The economy’s at risk of plunging into an air pocket, says JPMorgan. What that would mean for stocks.
Investors are brushing aside the possibilities of more turbulence to come for the U.S. economy and potential fallout for ...
Hikma Pharmaceuticals’ (HIK) “Overweight” Rating Reiterated at JPMorgan Chase & Co.
JPMorgan Chase & Co. restated their overweight rating on shares of Hikma Pharmaceuticals (LON:HIK – Free Report) in a report released on Friday morning, Marketbeat.com reports. Separately, Berenberg ...
Morningstar2d
JPMorgan Income Builder I
The team works with JPMorgan managers to curate underlying sleeves that fit the overall objective. As of the beginning of 2024, the duo worked closely with more than 20 underlying portfolio ...